Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


14 Items
Title  Creator  Group name  Publishing year 
Update on new treatments for rare ovarian tumours Quesada et al. EquipeADV 2022-11-28 00:00:00
Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database Bini et al. EquipeADV 2022-08-26 00:00:00
Maintenance endocrine therapy plus bevacizumab for advanced or metastatic breast cancer Quesada and Jacot EquipeADV 2022-04-11 00:00:00
Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy? Thomas et al. EquipeADV 2022-01-14 00:00:00
An Alternative Role of RluD in the Fidelity of Translation Initiation in Escherichia coli Lahry et al. EquipeADV 2022-04-19 00:00:00
The PIWI protein Aubergine recruits eIF3 to activate translation in the germ plasm Ramat et al. EquipeADV 2020-03-06 00:00:00
The ribosome, (slow) beating heart of cancer (stem) cell Bastide and David EquipeADV 2018-04-21 00:00:00
Mouse adult hematopoietic stem cells actively synthesize ribosomal RNA Jarzebowski et al. EquipeADV 2018-09-23 00:00:00
Interaction of rRNA with mRNA and tRNA in Translating Mammalian Ribosome: Functional Implications in Health and Disease Bastide and David EquipeADV 2018-09-29 00:00:00
Coevolution of the translational machinery optimizes initiation with unusual initiator tRNAs and initiation codons in mycoplasmas Ayyub et al. EquipeADV 2017-09-14 00:00:00
An improved analysis methodology for translational profiling by microarray Sbarrato et al. EquipeADV 2017-08-27 00:00:00
Protein Translation Activity: A New Measure of Host Immune Cell Activation Seedhom et al. EquipeADV 2016-07-08 00:00:00
Pregnane X-receptor promotes stem cell-mediated colon cancer relapse Planque et al. EquipeADV 2016-07-25 00:00:00
Antibiotics inhibit sphere-forming ability in suspension culture Relier et al. EquipeADV 2016-02-16 00:00:00
14 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés